Regulations.gov document
Mani RB_2002_Memorandum Summarizing Review and Eval of Clinical Data on Phosphatidylserine…
Supporting & Related Material · FDA-2016-Q-1523 · posted Jan 31, 2019
Key facts
| Document ID | FDA-2016-Q-1523-0150 |
|---|---|
| Title | Mani RB_2002_Memorandum Summarizing Review and Eval of Clinical Data on Phosphatidylserine and Cognitive Impairment_FDA |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2016-Q-1523 |
| Posted | Jan 31, 2019 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: